Press Release

FreedomWorks Foundation Statement in Response to the White House Decision to Sign Buy American Executive Order

08/06/2020

WASHINGTON, D.C. -- In response to the White House issuing a Buy American executive order for pharmaceutical products, Adam Brandon, FreedomWorks President, commented:

“A sheer 72 percent of the supply chain for active pharmaceutical ingredients is based overseas. This executive order threatens to disrupt not only a major sector of our economy, but one that is integral to fighting the COVID crisis. This will be an incredibly costly, harmful measure if implemented.

“Much of the good this administration has done has stemmed from the instinct to let private industry operate without the heavy hand of government. This order cuts directly against that recipe for success and we urge the administration to reconsider the consequences of this executive action.”

Tags Trade, IPI, price controls, pharmaceutical drugs, Donald Trump

Press Release

FreedomWorks Statement in Response to Senate Democrats’ Socialist Drug Pricing Scheme

BY Adam Brandon

WASHINGTON, D.C. -- In response to Senate Democrats’ socialist drug pricing scheme, Adam Brandon, FreedomWorks President, commented:

11/02/2021

Blog

House Democrats Miss the Mark on Drug Pricing

BY Luke Hogg

The Big Picture

09/15/2021

Press Release

FreedomWorks Foundation Files Comments Regarding FTC’s Pharmaceutical Merger Proposal

BY Peter Vicenzi

WASHINGTON, D.C.-- This past week, FreedomWorks Foundation and activists from 25 states filed comments before the Federal Trade Commission (FTC). Along with its international counterparts, the Justice Department, and state attorneys general, the FTC requested public input on evaluating pharmaceutical mergers. Steve Moore, FreedomWorks Senior Economist, commented:

06/28/2021

Blog

FreedomWorks Leads Letter to Oklahoma Senate Opposing Prescription Drug Price Controls in SB 734

BY Sarah Anderson

Today, FreedomWorks President Adam Brandon sent a letter alongside 190 of our Oklahoma activists to the Oklahoma State Senate in strong opposition to Senate Bill 734: An Act relating to prescription drugs

03/09/2021

Blog

Support the Stop PPE Taxes Act, S. 4497

BY Adam Brandon

On behalf of FreedomWorks’ activist community, I urge you to contact your senators and ask them to cosponsor the Stop PPE Taxes Act, S. 4497, introduced by Sen. Pat Toomey (R-Pa.). This legislation would temporarily remove import duties and tariffs from personal protective equipment (PPE) being used to combat the COVID-19 pandemic.

11/30/2020

Blog

Regulatory Action Center Review - October 8, 2020

BY Daniel Savickas

Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on here in the swamp. We offer resources for you to get involved in the rulemaking process to hold unelected bureaucrats accountable and occasionally offer praise in the event they have a good impulse. We will also highlight the incredible work our activists have done to advance the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law. For more ways to get involved and stay informed, check the links at the bottom of this post.

10/08/2020

Blog

FreedomWorks Launches International Reference Pricing Scorecard

BY Daniel Savickas

FreedomWorks Foundation’s Regulatory Action Center (RAC) has launched a scorecard for the 16 nations to which the Department of Health and Human Services (HHS) wants to tie the United States when it comes to prescription drug prices. The scorecard shows what most in Washington should already know: price controls are a surefire prescription for failure.

10/07/2020

Press Release

FreedomWorks Foundation Launches MFN Drug Price Controls Scorecard

BY Peter Vicenzi

WASHINGTON, D.C. -- FreedomWorks Foundation today announces the launch of its Most Favored Nations (MFN) Drug Price Controls Scorecard. The Scorecard notes the prevalence of four key indicators related to an MFN drug price control proposal: reduced access to meds, long wait times for health services, a single payer system, and equipment shortages. The preponderance of these characteristics in 17 other developed countries is noted on the scorecard.

10/06/2020

Blog

Regulatory Action Center Review - September 24, 2020

BY Daniel Savickas

09/24/2020

Press Release

FreedomWorks Statement in Response to August 2020 Jobs Numbers

BY Peter Vicenzi

WASHINGTON, D.C. -- In response to the report this morning from the Bureau of Labor Statistics that shows that U.S. unemployment fell to 8.4 percent during the month of August, 2020, Steve Moore, Chairman of the FreedomWorks Task Force on Economic Revival, commented:

09/04/2020